Fundraising Fox

Azitra

NYSE: AZTR

Farmington, US · Founded 2014 · Delaware corporation · 2 known investors

Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology. The company leverages a proprietary platform combining a microbial library of approximately 1,500 bacterial strains with AI/ML-powered screening and genetic engineering technology.

AI & Machine LearningBiotechHealthtech

Founders & leadership

AM
Azim MunivarNamed on SEC filing

Board

SRStella Robertson
Stella RobertsoninBoard directorCo-Founder and Partner at Bios Partners
TWTravis Whitfill
Travis Whitfillin𝕏Board directorPartner at Bios Partners30 Under 30 2018

Investors · 2

Bios PartnersreportedFort Worthvia Travis Whitfill · board
KdT Venturesreported · 2 sourcesAustin · $500K – $3Mvia Cain McClary · board

Funding

SEC filings, press & company announcements

$32.1M disclosed across 6 of 7 rounds · 2017–2026

  • Undisclosed amountPIPE financingMar 2026
    Source ↗
▶$4.3MraisedOct 2022 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • STELLA ROBERTSONDirector
  • FRANCISCO SALVAExecutive Officer, Director
  • TRAVIS WHITFILLDirector
  • NAVEEN KRISHANDirector
  • ANDREW MCCLARYDirector
Offering amount
$4.5M
Amount sold
$4.3M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedJan 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Travis WhitfillDirector
  • Lucio IannoneDirector
  • Andrew McClaryDirector
  • Stella RobertsonDirector
  • Richard AndrewsExecutive Officer, Director
Offering amount
$2M
Amount sold
$1M
First sale
Jan 2021
Incorporated
Corporation, Connecticut
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17MraisedSep 2020 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cain McClaryDirector
  • Travis WhitfillDirector
  • Stella RobertsonDirector
  • Lucio IannoneDirector
  • Ricahrd AndrewsExecutive Officer, Director
Offering amount
$17M
Amount sold
$17M
First sale
Sep 2020
Incorporated
Corporation, Connecticut
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedMar 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard AndrewsExecutive Officer, Director
  • Stella RobertsonDirector
  • Travis WhitfillDirector
  • Andrew McClaryDirector
Offering amount
$17.3M
Amount sold
$4.7M
First sale
Feb 2019
Incorporated
Corporation, Connecticut, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedApr 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Travis WhitfillExecutive Officer, Director
  • Richard AndrewsExecutive Officer, Director, Promoter
  • Daniel WagnerDirector
  • Azim MunivarDirector
  • Stella RobertsonDirector
Offering amount
$2.5M
Amount sold
$2.1M
First sale
Apr 2018
Incorporated
Corporation, Connecticut, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedMar 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Azim MunivarExecutive Officer, Director, Promoter
  • Stella RobertsonDirector
  • Travis WhitfillExecutive Officer, Director, Promoter
Offering amount
$3.7M
Amount sold
$2.9M
First sale
Mar 2017
Incorporated
Corporation, Connecticut, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap
Robinhood14 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha10 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
IQVIA10 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
StockTwits10 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Public9 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.

Companies competing with Azitra for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase II2019$719.7K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$225K
National Science FoundationPhase ISTTR2017$225K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2016$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

/C O R R E C T I O N -- Azitra, Inc./ - AOLaol.com · Jul 2026Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyondprnewswire.com · Jun 2026Azitra raises $10.5M via PIPE financing | AZTR 8-K Filingstocktitan.net · Mar 2026CT biotech raises up to $31.4M amid listing compliance pushhartfordbusiness.com · Mar 2026Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Millionprnewswire.com · Mar 2026Branford’s Azitra raises $17M in round led by Bayerhartfordbusiness.com · Oct 2020

Frequently asked questions

What does Azitra do?
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology. The company leverages a proprietary platform combining a microbial library of approximately 1,500 bacterial strains with AI/ML-powered screening and genetic engineering technology.
Who are Azitra's investors?
Azitra's investors include Bios Partners, KdT Ventures.
How much funding has Azitra raised?
Azitra has disclosed $32.1M raised across 6 of its 7 known rounds.
Where is Azitra headquartered?
Azitra is headquartered in Farmington, US.